Finance

Beta
Lists
4534:TYO
Mochida Pharmaceutical Co Ltd
Â¥3,450.00
+1.02%
(+35.00) 1D
May 29, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4534...
Open
Â¥3,415
High
Â¥3,450
Low
Â¥3,395
Mkt. cap
125.55B
Avg. vol.
127.12K
Volume
139.30K
Dividend
2.32%
Quarterly dividend
Â¥20
Ex-dividend date
Mar 30, 2026
P/E ratio
15.48
52-wk high
Â¥3,965
52-wk low
Â¥2,859
EPS
Â¥223
Shares outstanding
19.85M
No. of employees
2K
Open
Â¥3,415
High
Â¥3,450
Low
Â¥3,395
Mkt. cap
125.55B
Avg. vol.
127.12K
Volume
139.30K
Dividend
2.32%
Quarterly dividend
Â¥20
Ex-dividend date
Mar 30, 2026
P/E ratio
15.48
52-wk high
Â¥3,965
52-wk low
Â¥2,859
EPS
Â¥223
Shares outstanding
19.85M
No. of employees
2K
News stories
From sources across the web
Profile
Mochida Pharmaceutical Co., Ltd is a Japanese pharmaceutical company. One of its products is the antidepressant setiptiline. Wikipedia
About Mochida Pharmaceutical Co Ltd
CEO-
Employees1.51K
FoundedApr 28, 1945
HeadquartersShinjuku City, Tokyo, Japan
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
26.63B
28.35B
32.50B
29.46B
Cost of goods sold
13.00B
15.13B
17.50B
15.06B
Cost of revenue
13.00B
15.13B
17.50B
15.06B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.05B
10.83B
12.45B
11.78B
Operating expense
11.05B
10.83B
12.45B
11.78B
Total operating expenses
24.06B
25.96B
29.94B
26.84B
Operating income
2.57B
2.40B
2.56B
2.62B
Other non operating income
25.00M
31.00M
-67.00M
12.00M
EBT including unusual items
2.78B
2.40B
3.17B
2.82B
EBT excluding unusual items
2.78B
2.40B
3.17B
2.85B
Income tax expense
888.00M
435.00M
681.00M
1.26B
Effective tax rate
31.92%
18.15%
21.50%
44.72%
Other operating expenses
-
-
-
-
Net income
1.89B
1.96B
2.49B
1.56B
Net profit margin
7.11%
6.92%
7.65%
5.30%
Earnings per share
-
-
-
-
Interest and investment income
251.00M
42.00M
232.00M
42.00M
Interest expense
-
-1.00M
-29.00M
-42.00M
Net interest expenses
251.00M
41.00M
203.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
3.11B
-
3.37B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more